(Total Views: 593)
Posted On: 05/28/2020 5:11:40 PM
Post# of 145890
FDA was recommending not doing EUA because it would make enrollment harder, to wait for full enrollment...at least that's what I understood NP to be saying. They can say that in a completely generic, non-committal way, with no judgement on the merits of leronlimab in particular.
(1)
(0)